BioFactura's Series A Round

BioFactura raised a round of funding on April 26, 2016.

BioFactura develops and commercializes biodefense drugs, client-selected novel drugs, and high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFast…

Articles about BioFactura's Series A Round: